Asep Medical Holdings Inc. Announces Additional Listing to the OTCQB Venture Market in the U.S. by asepadmin | Apr 26, 2022 | Uncategorized
Asep Medical Holdings Inc. Announces Compelling Results of an Independent Sepsis Study Prepared by RTI Health Solutions by asepadmin | Mar 22, 2022 | Uncategorized
Asep Medical Holdings Inc. to Hold Online Investor Information Webinar on March 3, 2022 by asepadmin | Mar 3, 2022 | Uncategorized
Asep Medical Inc. Announces its Antibiofilm/Anti-inflammatory Peptide Technology is in Advanced Development for Wound Dressings with US Army Funding1 by asepadmin | Feb 19, 2022 | Uncategorized
Asep Medical Holdings Inc. Announces an Exclusive Licensing Arrangement for a Patented and Novel AI-Driven Sepsis Diagnosis Technology Developed at the University of British Columbia (UBC) by asepadmin | Feb 2, 2022 | Uncategorized
